These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 18365384

  • 1. Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience.
    Ozawa M, Rebellato LM, Terasaki PI, Tong A, Briley KP, Catrou P, Haisch CE.
    Clin Transpl; 2006; ():265-90. PubMed ID: 18365384
    [Abstract] [Full Text] [Related]

  • 2. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.
    Transpl Immunol; 2012 Mar 27; 26(2-3):81-7. PubMed ID: 22182633
    [Abstract] [Full Text] [Related]

  • 5. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Mar 27; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure.
    Terasaki P, Lachmann N, Cai J.
    Clin Transpl; 2006 Mar 27; ():455-62. PubMed ID: 18365403
    [Abstract] [Full Text] [Related]

  • 9. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N, Terasaki PI, Schönemann C.
    Clin Transpl; 2006 Mar 27; ():171-99. PubMed ID: 18365377
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
    van den Berg-Loonen EM, Terasaki P, Kohanof S, Christiaans MH.
    Clin Transpl; 2006 Mar 27; ():305-22. PubMed ID: 18365386
    [Abstract] [Full Text] [Related]

  • 11. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Mar 27; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 12. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May 27; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S.
    Transplantation; 2009 Jun 15; 87(11):1681-8. PubMed ID: 19502960
    [Abstract] [Full Text] [Related]

  • 15. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J, Mihatsch MJ, Dragun D, Schaub S.
    Transplantation; 2008 Jun 15; 85(11):1557-63. PubMed ID: 18551059
    [Abstract] [Full Text] [Related]

  • 16. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Jun 15; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 17. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.
    Transplantation; 2009 Jul 27; 88(2):226-30. PubMed ID: 19623018
    [Abstract] [Full Text] [Related]

  • 18. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody.
    Mizutani K, Terasaki PI, Shih RN, Pei R, Ozawa M, Lee J.
    Hum Immunol; 2006 Mar 27; 67(3):223-9. PubMed ID: 16698446
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov 27; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.